The Clinical Utility of <i>FLT3</i> Mutation Testing in Acute Leukemia: A Canadian Consensus
FMS-like tyrosine kinase 3 (<i>FLT3</i>) mutations are detected in approximately 20–30% of patients with acute myeloid leukemia (AML), with the presence of a <i>FLT3</i> internal tandem duplication (<i>FLT3</i>-ITD) mutation being associated with an inferior outcome. Assessment of <i>FLT3</i> mutati...
Sparad:
| Huvudupphov: | , , , , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
MDPI AG
2023-12-01
|
| Serie: | Current Oncology |
| Ämnen: | |
| Länkar: | https://www.mdpi.com/1718-7729/30/12/759 |
| Taggar: |
Inga taggar, Lägg till första taggen!
|
